statistiche ricercatore

Continente	#
NA - Nord America	819
AS - Asia	337
EU - Europa	219
SA - Sud America	50
Continente sconosciuto - Info sul continente non disponibili	13
AF - Africa	9
OC - Oceania	1
Totale	1.448

Nazione	#
US - Stati Uniti d'America	794
SG - Singapore	123
CN - Cina	99
BR - Brasile	44
IT - Italia	42
HK - Hong Kong	39
DE - Germania	35
UA - Ucraina	35
FI - Finlandia	24
VN - Vietnam	24
GB - Regno Unito	23
CA - Canada	16
RU - Federazione Russa	14
TR - Turchia	13
FR - Francia	11
IE - Irlanda	8
IN - India	7
AT - Austria	6
BD - Bangladesh	6
ID - Indonesia	6
ES - Italia	5
IQ - Iraq	5
JP - Giappone	5
SE - Svezia	4
ZA - Sudafrica	4
BE - Belgio	3
PK - Pakistan	3
TT - Trinidad e Tobago	3
CR - Costa Rica	2
EC - Ecuador	2
NL - Olanda	2
OM - Oman	2
SK - Slovacchia (Repubblica Slovacca)	2
UY - Uruguay	2
AL - Albania	1
AU - Australia	1
CL - Cile	1
CO - Colombia	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
ET - Etiopia	1
GD - Grenada	1
GP - Guadalupe	1
KE - Kenya	1
KG - Kirghizistan	1
LA - Repubblica Popolare Democratica del Laos	1
LV - Lettonia	1
MU - Mauritius	1
MX - Messico	1
MY - Malesia	1
NI - Nicaragua	1
PL - Polonia	1
PT - Portogallo	1
SA - Arabia Saudita	1
TN - Tunisia	1
UZ - Uzbekistan	1
Totale	1.435

Nome	#
Role of 18F-FDG PET/CT in restaging and follow-up of patients with uterine sarcomas	186
Clinical and prognostic value of 18 F-FDG PET/CT in recurrent endometrial carcinoma	169
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients	161
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients	153
Herpes gestationis associated with normal pregnancy or complete hydatiform mole: report of three cases	134
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients	131
Patterns of Recurrence and Clinical Outcome of Patients with Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response after Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study	121
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors	114
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors	105
Laparoscopic management of a large urethral leiomyoma	93
Fertility Sparing Team	81
Totale	1.448

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	42	0	0	0	3	1	4	0	6	4	5	6	13
2022/2023	91	10	4	3	4	7	19	0	18	16	1	7	2
2023/2024	93	5	3	15	8	3	23	2	4	17	4	1	8
2024/2025	221	1	3	2	23	14	29	16	11	27	18	47	30
2025/2026	501	50	57	30	85	71	38	86	14	13	36	15	6
2026/2027	163	13	22	34	94	0	0	0	0	0	0	0	0
Totale													1.448